Ray Dalio (Bridgewater Associates) disclosed increased in BIOCRYST PHARMACEUTICALS INC

Ray Dalio (Bridgewater Associates)Increased09058V103Guru Move

Ray Dalio (Bridgewater Associates) disclosed increased in BIOCRYST PHARMACEUTICALS INC

Ray Dalio (Bridgewater Associates) filed a 13F change in BIOCRYST PHARMACEUTICALS INC (09058V103) on 2026-05-15, covering period end 2026-03-31.

Action

Increased

Capital

$4,236,812 reported value

Institutional 13F Signals1 evidence source

Why it matters

This signal is anchored to the SEC filing date while retaining the underlying 13F period end.

Evidence

SEC 13F filing for Ray Dalio (Bridgewater Associates)

Filed 2026-05-15 20:06:56+00 · Period end 2026-03-31 · 0001350694-26-000002

Related Cards

New46137V357

Paul Tudor Jones II

Paul Tudor Jones II (Tudor Investment) filed a 13F change in Invesco S&P 500 Equal Weight Etf - US ETP (46137V357) on 2026-05-15, covering period end 2026-03-31.

Increased911549103

Steven Cohen

Steven Cohen (Point72) filed a 13F change in UNITED STATES ANTIMONY CORP (911549103) on 2026-05-15, covering period end 2026-03-31.